| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/14/2008 | WO2007103190A3 Transdermal treatment of tendinop athy using no donor |
| 08/14/2008 | WO2007102869A3 Treatment of ovarian cancer with clostridium perfringens enterotoxin |
| 08/14/2008 | WO2007087188A8 Taste-masked tablets and granules |
| 08/14/2008 | WO2007081835A3 Modulators of hypoxia inducible factor-1 and related uses |
| 08/14/2008 | WO2007076328A3 Rna interference mediated inhibition of hepatitis c virus |
| 08/14/2008 | WO2007072158A8 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 08/14/2008 | WO2007072153A8 Carbonylamino pyrrolopyrazoles, potent kinase inhibitors |
| 08/14/2008 | WO2007066189A3 Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea |
| 08/14/2008 | WO2007065288A8 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 08/14/2008 | WO2007064752A3 Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema |
| 08/14/2008 | US20080195183 selecting an area of skin from which reduced hair growth is desired, and applying to the area of skin, a composition comprising a TRPM8 agonist as the only active hair growth inhibitor and a dermatologically acceptable vehicle; wherein if the TRPM8 agonist is a terpene, then it is a cyclic terpene |
| 08/14/2008 | US20080195032 Photosensitizer formulations and their use |
| 08/14/2008 | US20080194867 Nateglinide crystals |
| 08/14/2008 | US20080194838 Carvedilol |
| 08/14/2008 | US20080194837 Potassium Channel Opener Having Benzofuroindole Skeleton |
| 08/14/2008 | US20080194806 Use of lipid conjugates in the treatment of diseases |
| 08/14/2008 | US20080194802 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use |
| 08/14/2008 | US20080194703 Method of Preparing Lycopene-Enriched Formulations That are Free of Organic Solvents, Formulations Thus Obtained, Compositions Comprising Said Formulations and Use of Same |
| 08/14/2008 | US20080194702 Obovatol Having Anti-Anxiety Activity |
| 08/14/2008 | US20080194701 DNA molecules isolated from Streptococcus agalactiae, comprising genes responsible for gamma -glutamyl-L-cysteinylglycine synthesis; drug design; treatment of infections caused by streptococcus agalactiae |
| 08/14/2008 | US20080194700 Use of Paeonol For Inhibiting Angiogenesis or For Enhancing Radiosensitization |
| 08/14/2008 | US20080194699 topical nitrogen mustard or salts in nonaqueous vehicles or carriers, used for treating skin disorders |
| 08/14/2008 | US20080194698 administering N-methyl-D-aspartate receptor antagonists, preferably memantine, neramexane or prodrugs; treatment of obesity, eating disorders and/or regulation of appetites |
| 08/14/2008 | US20080194697 ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane, used for treating prostate cancer, prostatitis and benign prostatic hyperplasia |
| 08/14/2008 | US20080194696 norepinephrine, serotonin and dopamine reuptake inhibitors such as 1-(3,4-dichlorophenyl)bicyclo[3.1.0]hexan-3-amine, used for the treatment and/or prevention of nervous system disorders; antidepressants; anxiolytic agents |
| 08/14/2008 | US20080194695 Pharmaceutical Composition Containing Sibutramine Free Base and Manufacturing Method Thereof |
| 08/14/2008 | US20080194694 nematocides such as N-{1-cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-pentafluorothiobenzamide, tautomers or prodrugs, carriers and optionally a second therapeutic agent, used for treating parasitic infestations |
| 08/14/2008 | US20080194692 Polymorphs of suberoylanilide hydroxamic acid |
| 08/14/2008 | US20080194691 Apoptosis Promoters |
| 08/14/2008 | US20080194690 Pharmaceutical Formulations Of Hdac Inhibitors |
| 08/14/2008 | US20080194688 Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 08/14/2008 | US20080194687 particle obtained by granulating 1-aminomethyl-cyclohexane-acetic acid with polyethylene glycol; antiepileptic agents |
| 08/14/2008 | US20080194686 mobilizing triacylglycerol in mammals by feeding the mammal a diet that includes betaine, cysteine and choline bitartrate, while restricting methionine intake; reduction of liver disorders; cirrhosis |
| 08/14/2008 | US20080194685 transgenic oilseed plant that produces mature seeds which have been transformed to produce high levels of 5,8,11,14-eicosatetraenoic acid (an omega-6 fatty acid) and a reduced content of omega-3 fatty acids; used in foods, drugs, beverages, dairy products, feeds or aquacultures |
| 08/14/2008 | US20080194684 administering lipid glycerides for treating neurodegenerative disease such as multiple sclerosis; increasing transforming growth factors and tumor necrosis factors |
| 08/14/2008 | US20080194683 Medicament for preventing and/or treating peripheral neuropathies |
| 08/14/2008 | US20080194682 administering inhibitors of endopeptidase such as thiorphan or candoxatril, to effect bone elongation; achondroplasia |
| 08/14/2008 | US20080194681 Novel Inhibitors of Histone Deacetylase for the Treatment of Disease |
| 08/14/2008 | US20080194680 Platinum analogs with bis-nitrile-containing ligands |
| 08/14/2008 | US20080194679 Administering an amino acid chelate including a multi-nitrogen-containing amino acid ligand and a metal to an animal; increased milk production, enhanced growth, enhanced fertility, reduced morbidity, reduced tissue fat, or enhanced feed conversion |
| 08/14/2008 | US20080194678 Process To Obtain Synthetic And Semi-Synthetic Lignan Derivatives, Their Antiparasitic Activities And Corresponding Pharmaceutical Formulations, Including The Therapeutic Method Using Said Lignan For The Treatment Of Parasitosis |
| 08/14/2008 | US20080194677 Transdermal fluid |
| 08/14/2008 | US20080194676 Formulations for oral administration of cromolyn sodium |
| 08/14/2008 | US20080194675 Mixture of Catechins or Rather Polyphenols Extracted from Chinese Green Tea or Other Vegetables for the Prevention of Prostate Cancer and for the Treatment of Prostate Hypertrophy (Bph) |
| 08/14/2008 | US20080194674 Cb2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antifibrogenic pathway in the liver |
| 08/14/2008 | US20080194672 Growth hormone secretagogue (ghrelin) receptor; gastrointestinal disorders; gastroesophageal reflux disease (GERD), gastric ulcers, Crohn's disease |
| 08/14/2008 | US20080194671 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 08/14/2008 | US20080194670 Novel Thiophene Derivatives as Spingosine-1-Phosphate-1 Receptor Agonists |
| 08/14/2008 | US20080194669 T Type Calcium Channel Blockers and the Treatment of Diseases |
| 08/14/2008 | US20080194668 4-[6-(4-Butyl-phenyl)-7-fluoro-1H-indol-2-yl]-benzoic acid; 4-[6-(4-Butyl-phenyl)-7-fluoro-1H-indol-2-yl]-2-chloro-phenylamine; thrombocytopenia; radiation therapy, chemotherapy, immune therapy, cancers, viral infections, and transplants such as bone marrow and stem cell transplants |
| 08/14/2008 | US20080194667 Compositions For Treating Amyloid Associated Diseases |
| 08/14/2008 | US20080194666 Gonadotropin-releasing hormone antagonist (GnRH antagonist); insecticides, nematocides and molluscicides; sexual disorders |
| 08/14/2008 | US20080194665 Compositions Based on Amino Acids for Improving the Myocardial Ventricular Function in Patients Suffering from Diabetes |
| 08/14/2008 | US20080194664 Avermectin/metronidazole compositions for treating afflictions of the skin, e.g., rosacea |
| 08/14/2008 | US20080194663 Novel sustained release polymer |
| 08/14/2008 | US20080194662 Cleanser composition |
| 08/14/2008 | US20080194661 1-(5-(4-trifluoromethyl-benzylamino)-1H-indazol-1-yl)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol; 2-(2,4-difluorophenyl)-1-(1H-indazol-1-yl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol |
| 08/14/2008 | US20080194660 Angiotensin II receptor antagonists |
| 08/14/2008 | US20080194659 Cinnamic, Phenylpropiolic and Phenylpropanoic Acid Derivatives Useful as Anti-Tumor Agents |
| 08/14/2008 | US20080194658 N-(4-{[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]amino}phenyl)acetamide; treating high serum levels of total cholesterol, low density lipoprotein and triglycerides |
| 08/14/2008 | US20080194657 Thiazole Derivatives for Treating Restless Legs Syndrome |
| 08/14/2008 | US20080194656 Benzotriazole Derivatives as Cannabinoid Receptor Antagonists |
| 08/14/2008 | US20080194655 Zero order controlled release compositions of tizanidine |
| 08/14/2008 | US20080194654 Using monoamine oxidase inhibitor; prevention, therapy of gastrointestinal disorders; sexual disorders; antidepressants; cognition activators; analgesics |
| 08/14/2008 | US20080194653 Using a thiadiazole drug; anticancer agents |
| 08/14/2008 | US20080194652 Inactive isomer compositions for use as drug-resistance-reversal agents and in prophylactic treatment |
| 08/14/2008 | US20080194651 Nitroderivatives as drugs for diseases having an inflammatory basis |
| 08/14/2008 | US20080194650 Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents |
| 08/14/2008 | US20080194649 Mixture of parasympathetic agents and sympathetic agent and local anesthetic; injection into eye before laser therapy |
| 08/14/2008 | US20080194648 glutamate receptors agonists; especially to treat psychotic conditions, including schizophrenia and enhancement of cognition; N-{-2-[4-(6-fluoro-3-pyridinyl)phenyl]cyclopropyl}-2-propanesulfonamide |
| 08/14/2008 | US20080194647 Pyridyl Derivatives and Their Use as Mglu5 Antagonists |
| 08/14/2008 | US20080194646 Using phenoxyacetic acid as anticancer agents; peroxisome proliferator activator moderator |
| 08/14/2008 | US20080194645 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 08/14/2008 | US20080194644 Controlling dosage; side effect reduction |
| 08/14/2008 | US20080194643 Using pyrrolidonedicarboxamide compound; therapy for thrombosis, cardiovascular disorders; myocardoim infraction; restenosis; atherosclerosis; anticancer agents; sepsis; antidiabetic agents |
| 08/14/2008 | US20080194642 Topical administering to animals |
| 08/14/2008 | US20080194640 Optically Active Tetrahydronaphthalene Derivative |
| 08/14/2008 | US20080194639 Proton Pump Inhibitors in the Treatment of Sleep Disturbance Due to Silent Gastroesophageal Reflux |
| 08/14/2008 | US20080194638 Bioavailable formulations of heterocyclic compounds |
| 08/14/2008 | US20080194637 Small organic molecule regulators of cell proliferation |
| 08/14/2008 | US20080194636 Controlling insulin aminiopeptidase; cognition activators; induction labor and lactation; side effecxt reduction |
| 08/14/2008 | US20080194635 Antiinflammatory agents; respiratory system disorders; cystic fibrosis; antihistamines; inflammatory bowel disorders; COPD; Crohn's disease; gastrointestinal disorders |
| 08/14/2008 | US20080194633 E.g., [(1-(2-aminoacetyl)-4-{N-[(3-fluoro-2-methylphenyl)methyl]carbamoyl}(4-piperidyl))methoxy]-N-(4-ethylphenyl)carboxamide; smooth muscle myosin or non-muscle myosin modulator; hypotensive agent; asthma, COPD, bronchoconstrictive disease, glaucoma, pre-menstrual cramps, erectile dysfunction |
| 08/14/2008 | US20080194632 Antiinflammatyory agents; asthma therapy; chronic obstructive pilmonary disease |
| 08/14/2008 | US20080194631 Concurrent antagonist of noradrenergic, n-Methylaspartic acid and serotonine receptors ; therapy for psychological disorders, nicotine addiction; alcoholism; sleep disorders; schizophrenia; hyperactivity |
| 08/14/2008 | US20080194630 LTA4H modulators and uses thereof |
| 08/14/2008 | US20080194629 3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors |
| 08/14/2008 | US20080194628 Alzheimer's disease; cognition activators |
| 08/14/2008 | US20080194627 Aryl substituted pyridines and the use thereof |
| 08/14/2008 | US20080194626 Antihypertensive drug combination |
| 08/14/2008 | US20080194625 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 08/14/2008 | US20080194624 Drug for Alzheimer's disease; cognition activators; strokes; down's disease; Parkinson's disease |
| 08/14/2008 | US20080194623 Reacting chemical intermediate quinoline compound with carbonyldiimidazole |
| 08/14/2008 | US20080194622 Antidepressants; anxiolytic agents;schizophrenia; cognition activators |
| 08/14/2008 | US20080194621 Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, pharmaceutical compositions and therapeutic use |
| 08/14/2008 | US20080194620 Use of Benzodiazepine Receptor Ligands For Combating Signs of Ageing |
| 08/14/2008 | US20080194619 Viricide against retrovirus infection; antiproliferative agents; 4-aminophenyl(1-azabicyclo92.2.2)ocy-4-yl)methanone |
| 08/14/2008 | US20080194618 Muscle relaxants; respiratory system disorders; asthma; COPD; emphysema; bronchitis |
| 08/14/2008 | US20080194617 Fused ring compound |
| 08/14/2008 | US20080194616 Analgesics; antidepressants; cardiovascular disorders; respiratory system disorders; antiinflammatory agents; inflammatory bowel disorders; headaches |